This necessitates large-scale vaccine production, a process that often presents significant challenges. Vaccine production employs a range of diverse and evolving technologies, from traditional ...

Prof. Si Longlong's team from the Shenzhen Institutes of Advanced Technology of the Chinese Academy of Sciences constructed a ...

Novavax, the little-known Maryland company that received a $1.6 billion deal from the federal government for its experimental coronavirus vaccine, announced encouraging results in two preliminary ...

The agreement is valued at over $3 billion and increases U.S. manufacturing capacity to help ensure patient access to ...

Biopharmaceutical giant Merck (NYSE: MRK) has broken ground on a $1 billion pharmaceutical manufacturing facility in Wilmington, about 30 miles southwest of Philadelphia. Known as Merck Wilmington ...

Vaccine-preventable diseases cost African countries a staggering USD 13 billion each year in direct and indirect expenses.

Roche projected that its $50 billion manufacturing investment, to include R&D operations, will generate 1,000 jobs at the ...

Introduction: The DNA of a Biotech BoomThe global plasmid DNA manufacturing market is entering a transformative era, driven by revolutionary advancements in gene therapy, cancer immunotherapy, DNA ...

Moderna's cash infusion from covid vaccine sales in 2021-22, as well as newly established large-scale manufacturing facilities, positions the firm to rapidly develop new pipeline programs.

Dyadic International, Inc., is a biotechnology company that utilizes its microbial production platforms to develop commercial cell lines focused on the efficient large-scale manufacture of proteins ...